Toby Mansell1,2, Anne-Louise Ponsonby1,2,3, Fiona Collier1,4,5, David Burgner1,2,6, Peter Vuillermin1,4,5, Katherine Lange1,2, Joanne Ryan1,7, Richard Saffery8,9. 1. Murdoch Children's Research Institute, Parkville, VIC, Australia. 2. Department of Paediatrics, University of Melbourne, Parkville, VIC, Australia. 3. The Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia. 4. School of Medicine, Deakin University, Geelong, VIC, Australia. 5. Child Health Research Unit, Barwon Health, Geelong, VIC, Australia. 6. Department of Paediatrics, Monash University, Clayton, VIC, Australia. 7. Department of Epidemiology and Preventative Medicine, Monash University, Clayton, VIC, Australia. 8. Murdoch Children's Research Institute, Parkville, VIC, Australia. richard.saffery@mcri.edu.au. 9. Department of Paediatrics, University of Melbourne, Parkville, VIC, Australia. richard.saffery@mcri.edu.au.
Abstract
BACKGROUND: Leptin regulates satiety and energy homoeostasis, and plays a key role in placentation in pregnancy. Previous studies have demonstrated regulation of leptin gene (LEP) expression and/or methylation in placenta and cord blood in association with early life exposures, but most have been small and have not considered the influence of genetic variation. Here, we investigated the relationship between maternal factors in pregnancy, infant anthropometry and LEP genetic variation with LEP promoter methylation at birth and 12 months of age. METHODS: LEP methylation was measured in cord (n = 877) and 12-month (n = 734) blood in the Barwon Infant Study, a population-based pre-birth cohort. Infant adiposity at birth and 12-months was measured as triceps and subscapular skinfold thickness. Cross-sectional regression tested associations of methylation with pregnancy and anthropometry measures, while longitudinal regression tested if birth anthropometry predicted 12-month LEP methylation levels. RESULTS: Male infants had lower LEP methylation in cord blood (-2.07% average methylation, 95% CI (-2.92, -1.22), p < 0.001). Genetic variation strongly influenced DNA methylation at a single CpG site, which was also negatively associated with birth weight (r = -0.10, p = 0.003). Pre-eclampsia was associated with lower cord blood methylation at another CpG site (-6.06%, 95% CI (-10.70, -1.42), p = 0.01). Gestational diabetes was more modestly associated with methylation at two other CpG units. Adiposity at birth was associated with 12-month LEP methylation, modified by rs41457646 genotype. There was no association of LEP methylation with 12-month anthropometric measures. CONCLUSIONS: Infant sex, weight, genetic variation, and exposure to pre-eclampsia and gestational diabetes, are associated with LEP methylation in cord blood. Infant adiposity at birth predicts 12-month blood LEP methylation in a genotype-dependent manner. These findings are consistent with genetics and anthropometry driving altered LEP epigenetic profile and expression in infancy. Further work is required to confirm this and to determine the long-term impact of altered LEP methylation on health.
BACKGROUND:Leptin regulates satiety and energy homoeostasis, and plays a key role in placentation in pregnancy. Previous studies have demonstrated regulation of leptin gene (LEP) expression and/or methylation in placenta and cord blood in association with early life exposures, but most have been small and have not considered the influence of genetic variation. Here, we investigated the relationship between maternal factors in pregnancy, infant anthropometry and LEP genetic variation with LEP promoter methylation at birth and 12 months of age. METHODS:LEP methylation was measured in cord (n = 877) and 12-month (n = 734) blood in the Barwon Infant Study, a population-based pre-birth cohort. Infant adiposity at birth and 12-months was measured as triceps and subscapular skinfold thickness. Cross-sectional regression tested associations of methylation with pregnancy and anthropometry measures, while longitudinal regression tested if birth anthropometry predicted 12-month LEP methylation levels. RESULTS: Male infants had lower LEP methylation in cord blood (-2.07% average methylation, 95% CI (-2.92, -1.22), p < 0.001). Genetic variation strongly influenced DNA methylation at a single CpG site, which was also negatively associated with birth weight (r = -0.10, p = 0.003). Pre-eclampsia was associated with lower cord blood methylation at another CpG site (-6.06%, 95% CI (-10.70, -1.42), p = 0.01). Gestational diabetes was more modestly associated with methylation at two other CpG units. Adiposity at birth was associated with 12-month LEP methylation, modified by rs41457646 genotype. There was no association of LEP methylation with 12-month anthropometric measures. CONCLUSIONS:Infant sex, weight, genetic variation, and exposure to pre-eclampsia and gestational diabetes, are associated with LEP methylation in cord blood. Infant adiposity at birth predicts 12-month blood LEP methylation in a genotype-dependent manner. These findings are consistent with genetics and anthropometry driving altered LEP epigenetic profile and expression in infancy. Further work is required to confirm this and to determine the long-term impact of altered LEP methylation on health.
Authors: E D Green; M Maffei; V V Braden; R Proenca; U DeSilva; Y Zhang; S C Chua; R L Leibel; J Weissenbach; J M Friedman Journal: Genome Res Date: 1995-08 Impact factor: 9.043
Authors: Jessica F Briffa; Andrew J McAinch; Tania Romano; Mary E Wlodek; Deanne H Hryciw Journal: Am J Physiol Endocrinol Metab Date: 2014-12-16 Impact factor: 4.310
Authors: Esther Frances Davis; Merzaka Lazdam; Adam James Lewandowski; Stephanie Anne Worton; Brenda Kelly; Yvonne Kenworthy; Satish Adwani; Andrew R Wilkinson; Kenny McCormick; Ian Sargent; Christopher Redman; Paul Leeson Journal: Pediatrics Date: 2012-05-21 Impact factor: 7.124